SCHEMBL8077463

SCHEMBL8077463

O=C(CCl)Cc1ccc2ccccc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NR1H4 Q96RI1 1/20 0.49
CYP1A2 P05177 2/20 0.49
VNN1 O95497 1/20 0.48
BCHE P06276 1/20 0.48
HTR2C P28335 1/20 0.48
ADRA1A P35348 1/20 0.48
HTR2B P41595 1/20 0.48
HTR6 P50406 1/20 0.48
SLC6A3 Q01959 1/20 0.48
NLRP3 Q96P20 1/20 0.48
CYP2A6 P11509 1/20 0.47
GSK3A P49840 1/20 0.47
MAPK10 P53779 1/20 0.47
RIOK2 Q9BVS4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MC4R P32245 1/20 0.46
MC3R P41968 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4310873 0.88 ALOX5 (0.56) ALOX5MEN1KMT2ANR1H4CYP1A2
SCHEMBL21705053 0.83 NR1H4 (0.58) ALOX5MEN1KMT2ANR1H4CYP1A2
SCHEMBL6341622 0.83 ALOX5 (0.51) ALOX5MEN1KMT2ANR1H4CYP1A2
SCHEMBL11634753 0.82 ALOX5 (0.50) ALOX5MEN1KMT2ANR1H4CYP1A2
SCHEMBL3892546 0.82 CYP1A2 (0.50) ALOX5MEN1KMT2ANR1H4CYP1A2
SCHEMBL13061973 0.81 CYP1A2 (0.57) ALOX5MEN1KMT2ANR1H4CYP1A2
SCHEMBL29651866 0.81 ALOX5 (0.53) ALOX5MEN1KMT2ANR1H4CYP1A2
SCHEMBL1020432 0.81 ALOX5 (0.53) ALOX5MEN1KMT2ANR1H4CYP1A2
SCHEMBL5403251 0.80 ALOX5 (0.49) ALOX5MEN1KMT2ANR1H4CYP1A2
Methane SCHEMBL28079584 0.79 ALOX5 (0.51) ALOX5MEN1KMT2ANR1H4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0968209-A1 THIAZOLE BENZENESULFONAMIDES AS $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY Merck & Co., Inc. (US) 2000-01-05 EP disclosed
US-6011048-A Thiazole benzenesulfonamides as β3 agonists for treatment of diabetes and obesity MERCK & CO., INC. (US) 2000-01-04 US disclosed
WO-1998032753-A1 THIAZOLE BENZENESULFONAMIDES AS β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY MERCK & CO., INC. (US) 1998-07-30 WO disclosed